Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity

被引:244
作者
Baer, Caroline [1 ]
Squadrito, Mario Leonardo [1 ]
Laoui, Damya [1 ]
Thompson, Danielle [1 ]
Hansen, Sarah K. [1 ]
Kiialainen, Anna [2 ]
Hoves, Sabine [3 ]
Ries, Carola H. [3 ]
Ooi, Chia-Huey [2 ,3 ]
De Palma, Michele [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland
[2] Roche Innovat Ctr Basel Pharmaceut Sci Pharma Res, CH-4070 Basel, Switzerland
[3] Roche Innovat Ctr Munich Oncol Discovery Pharma, D-82377 Penzberg, Germany
基金
瑞士国家科学基金会;
关键词
TUMOR-ASSOCIATED MACROPHAGES; TIE2-EXPRESSING MONOCYTES; NEGATIVE REGULATION; CANCER; CELLS; DICER; EXPRESSION; RECEPTOR; RNA; GENERATION;
D O I
10.1038/ncb3371
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-gamma/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-gamma exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-gamma-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.
引用
收藏
页码:790 / +
页数:17
相关论文
共 70 条
[51]
CSF-1/CSF-1R targeting agents in clinical development for cancer therapy [J].
Ries, Carola H. ;
Hoves, Sabine ;
Cannarile, Michael A. ;
Ruettinger, Dominik .
CURRENT OPINION IN PHARMACOLOGY, 2015, 23 :45-51
[52]
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy [J].
Ries, Carola H. ;
Cannarile, Michael A. ;
Hoves, Sabine ;
Benz, Joerg ;
Wartha, Katharina ;
Runza, Valeria ;
Rey-Giraud, Flora ;
Pradel, Leon P. ;
Feuerhake, Friedrich ;
Klaman, Irina ;
Jones, Tobin ;
Jucknischke, Ute ;
Scheiblich, Stefan ;
Kaluza, Klaus ;
Gorr, Ingo H. ;
Walz, Antje ;
Abiraj, Keelara ;
Cassier, Philippe A. ;
Sica, Antonio ;
Gomez-Roca, Carlos ;
de Visser, Karin E. ;
Italiano, Antoine ;
Le Tourneau, Christophe ;
Delord, Jean-Pierre ;
Levitsky, Hyam ;
Blay, Jean-Yves ;
Ruettinger, Dominik .
CANCER CELL, 2014, 25 (06) :846-859
[53]
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF [J].
Rolny, Charlotte ;
Mazzone, Massimiliano ;
Tugues, Sonia ;
Laoui, Damya ;
Johansson, Irja ;
Coulon, Cathy ;
Squadrito, Mario Leonardo ;
Segura, Inmaculada ;
Li, Xiujuan ;
Knevels, Ellen ;
Costa, Sandra ;
Vinckier, Stefan ;
Dresselaer, Tom ;
Akerud, Peter ;
De Mol, Maria ;
Salomaki, Henriikka ;
Phillipson, Mia ;
Wyns, Sabine ;
Larsson, Erik ;
Buysschaert, Ian ;
Botling, Johan ;
Himmelreich, Uwe ;
Van Ginderachter, Jo A. ;
De Palma, Michele ;
Dewerchin, Mieke ;
Claesson-Welsh, Lena ;
Carmeliet, Peter .
CANCER CELL, 2011, 19 (01) :31-44
[54]
gCMAP: user-friendly connectivity mapping with R [J].
Sandmann, Thomas ;
Kummerfeld, Sarah K. ;
Gentleman, Robert ;
Bourgon, Richard .
BIOINFORMATICS, 2014, 30 (01) :127-128
[55]
Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
[56]
Macrophage plasticity and polarization: in vivo veritas [J].
Sica, Antonio ;
Mantovani, Alberto .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (03) :787-795
[57]
miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis [J].
Sonda, Nada ;
Simonato, Francesca ;
Peranzoni, Elisa ;
Cali, Bianca ;
Bortoluzzi, Stefania ;
Bisognin, Andrea ;
Wang, Ena ;
Marincola, Francesco M. ;
Naldini, Luigi ;
Gentner, Bernhard ;
Trautwein, Christian ;
Sackett, Sara Dutton ;
Zanovello, Paola ;
Molon, Barbara ;
Bronte, Vincenzo .
IMMUNITY, 2013, 38 (06) :1236-1249
[58]
Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells [J].
Squadrito, Mario Leonardo ;
Baer, Caroline ;
Burdet, Frederic ;
Maderna, Claudio ;
Gilfillan, Gregor D. ;
Lyle, Robert ;
Ibberson, Mark ;
De Palma, Michele .
CELL REPORTS, 2014, 8 (05) :1432-1446
[59]
MicroRNA-mediated control of macrophages and its implications for cancer [J].
Squadrito, Mario Leonardo ;
Etzrodt, Martin ;
De Palma, Michele ;
Pittet, Mikael J. .
TRENDS IN IMMUNOLOGY, 2013, 34 (07) :350-359
[60]
miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages [J].
Squadrito, Mario Leonardo ;
Pucci, Ferdinando ;
Magri, Laura ;
Moi, Davide ;
Gilfillan, Gregor D. ;
Ranghetti, Anna ;
Casazza, Andrea ;
Mazzone, Massimiliano ;
Lyle, Robert ;
Naldini, Luigi ;
De Palma, Michele .
CELL REPORTS, 2012, 1 (02) :141-154